Lowering your intake of calories may increase your chances of losing weight, maintaining your weight loss, and living a healthier lifestyle
Additional triggers for EDKA include pregnancy, pancreatitis, glycogen storage disorders, surgery, infection, cocaine toxicity, cirrhosis, and insulin pump use.[4][5] T1D bariatric surgery patients experience DKA in over 20% of postoperative cases and may be especially prone to EDKA.[6] The newer oral antidiabetic SGLT2 inhibitors, canagliflozin, dapagliflozin, empagliflozin, or ertugliflozin, can also directly result in EDKA.[2][3][7][8][9][10] EDKA may be more common in patients with diabetes on SGLT2 inhibitors with lower body mass index and decreased glycogen stores.[1] Episodes can be triggered by surgery infection, trauma, a major illness, reduced food intake, persistent vomiting, gastroparesis, dehydration, and reduced insulin dosage.[11] Epidemiology Approximately 2.6% to 3.2% of DKA admissions are euglycemic.[7][12] DKA-associated with SGLT2 inhibitors has rates ranging from 0.16 to 0.76 events per 1000 patient-years in patients with type 2 diabetes
Canadian patients with pre-existing diabetic retinopathy should inform their ophthalmologist when starting Rybelsus and schedule monitoring appropriately
Evidence-Based Healing Strategies: 1
Pre-blend 12.5/2.5 mg + 2.5 mL BAC 5 mg/mL reta + 1 mg/mL cag
There are several risk factors regarding further adoption of the treatment
